Study title: A randomized, parallel, double-blind, placebo-controlled study to determine the onset of action and tolerability of PHZ 136 and Motrin IB in post-operative dental pain and a repeat dose evaluation
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Anesthesia and Analgesia | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: CLOPERASTINE | |||||
ATC code: M01AE01 | |||||
Document link: | |||||
Document date: | |||||
Study number: IA-US-06 (1995) | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |